Conjunctivitis and keratoconjunctivitis are two similar eye conditions. They both cause the eyes to become pink or red and may cause itchiness and irritation. Conjunctiva is the name for the mucous ...
Vernal keratoconjunctivitis (VK) is a chronic, severe allergic condition affecting the eyes. The disease causes inflammation of the protective outer layer of the eye — the cornea — as well as the ...
Keratoconjunctivitis is when you have both keratitis and conjunctivitis at the same time. Keratitis is inflammation of the cornea, the clear dome that covers the iris and the pupil. Conjunctivitis is ...
Please provide your email address to receive an email when new articles are posted on . Click here to read the Cover Story, "Pediatric board addresses when to start myopia treatment, alternatives to ...
This page lists all known medications that could potentially lead to 'Keratoconjunctivitis sicca' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
The approval was based on data from two randomized, multicenter, double-masked, vehicle-controlled trials that evaluated the efficacy and safety of Verkazia in patients with VKC. The Food and Drug ...
Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, allergic condition primarily affecting children and young adults. It is a seasonal allergic inflammatory disease of the eye with episodes of ...
Verkazia is an oil-in-water cationic emulsion that works by inhibiting T-cell activation and reducing the level of immune cells and mediators. Verkazia ® (cyclosporine ophthalmic emulsion) 0.1% is now ...
Purpose To report three cases of adenoviral keratoconjunctivitis in patients who have undergone photorefractive keratectomy and that just developed subepithelial infiltrates. Methods Description of ...
To study the processes involved in mediating conjunctival remodelling in vernal keratoconjunctivitis (VKC) by investigating the expression of integrin receptors, epidermal growth factor receptor (EGFR ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A phase 2/3 randomized, double-masked, ...